| Allen, Keith (Syngenta Biotechnology Inc. 200604) |
n. a. |
Syngenta (Group) |
Switzerland |
| Allen, Mark (Elevian 202209 CEO) |
Chief Executive Officer (CEO) |
Elevian |
|
| Allerberger, Franz (Austria (govt) 201005 Head Human Medicine Div of AGES) |
Professor |
Austria (govt) |
Austria |
| Alles, Mark (Celgene 201306 EVP + Global Head Hematology + Oncology) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Alles, Melanie (CSL Behring 201910– Senior Manager Global Pathogen Safety Suppart before Deutsche Bank) |
n. a. |
CSL (Group) |
Australia |
| Allgaier, Hermann (Merckle Biotec 200503 Managing Director) |
Managing Director |
Teva (Group) |
Germany |
| Allibert, Patrice (GenePOC 201607 CEO) |
Chief Executive Officer (CEO) |
Debiopharm (Group) |
Canada |
| Allmaier, Günter (Vienna University of Techology 201104 Professor) |
Professor |
Vienna University of Technology (TU Wien) |
Austria |
| Allocca, Antonietta (Tecan 201611) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
| Alloueche, Ali (Affiris 201112– CBO before GSK Biologicals before Novartis Vaccines and Diagnostics) |
Chief Business Officer (CBO) |
Affiris AG |
Austria |
| Almasi, Barna (Imaging Service AG 200906 CTO) |
Chief Technology/Technical Officer (CTO) |
Imaging Service AG |
Germany |
| Almstetter, Michael (Origenis 202012 Managing Director) |
Managing Director |
Origenis (Group) |
Germany |
| Alperstaedt, Melanie (ASC Ooncology 202102 Public Relations + Project Management LEFT 5/24) |
Public Relations Manager / Investor Relations Manager |
CellPhenomics (incl. ASC Oncology) (Group) |
Germany |
| Alpert, Amir (Immatics 202305 Director Technology Scouting + Development) |
n. a. |
Immatics (Group) |
Germany |
| Alramahy, Ehab (Biosynth 202309 SVP Head of Peptide Division) |
President/Director/Head Business Group/Unit/Division |
Biosynth (since 9/22) (Group) |
Switzerland |
| Alt, Eckhard (InGeneron 201710 Board Chairman) |
Board member |
InGeneron (Group) |
Germany |
| Altenbach, H.-J. (Univ Wuppertal 201005 Professor) |
Professor |
University of Wuppertal |
Germany |
| Altendorf, Matthias (Endress+Hauser 202401– Supervisory Board Chair before CEO 2014–202312) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
| Altenhofen, Wolfram (Leucocare AG 201207 VP Business Development) |
Business Development Manager / Strategy Manager |
Leukocare (Group) |
Germany |
| Altevogt, Peter (DKFZ 200607 Professor) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Althoff, Gioia (Sophia Genetics 201904 SVP Genomics) |
President/Director/Head Business Group/Unit/Division |
Sophia Genetics (Group) |
Switzerland |
| Althusmann, Bernd (Niedersachsen (govt) 202207 Minister of Economic Affairs) |
Minister |
Niedersachsen (govt region) |
Germany |
| Altmeyer, Mark (Arvelle Therapeutics 201902– CEO before Axovant Sciences + BMS + Otsuka America Pharmaceutical) |
Chief Executive Officer (CEO) |
Angelini (Group) |
Switzerland |
| Altorfer, Michael (Swiss Biotech Association 201811 CEO before Polyphor + Roche + Ciba-Geigy + Sandoz + UBS Warburg) |
Chief Executive Officer (CEO) |
Swiss Biotech Association (SBA) |
Switzerland |
| Altshuler, David (Vertex 201510 EVP Global Research + CSO before Broad Institute 200510) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Vertex Pharmaceuticals (Group) |
United States (USA) |
| Álvarez Sánchez, Herminia (Nagi Bioscience 202309 Marketing + Business Development) |
Sales Manager / Marketing Manager |
Nagi Bioscience S.A. |
Switzerland |
| Alvers, Michael R. (Transinsight 200609 Managing Director + co-founder) |
Managing Director |
Transinsight GmbH |
Germany |
| Amadori, Giovanna (Chiesi Group 202011 Head of Global Strategy + Corporate Development) |
Business Development Manager / Strategy Manager |
Chiesi (Group) |
Italy |
| Amann, Anton (Medical Univ Innsbruck 201009 Professor) |
Professor |
Medical University Innsbruck (MUI) |
Austria |
| Amann, Rudolf |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Amariglio, Roy (OrbiMed 201605– Principal before Bayer HealthCare) |
Principal (venture capital) |
OrbiMed (Group) |
United States (USA) |
| Amberger, Christoph (KWS 201207 Executive Board Member responsible for corn) |
Board member, executive |
KWS Saat (Group) |
Germany |
| Ambros, Reinhard (Versameb 201910c Board Chairman + Novartis Venture Fund) |
Board member, non-executive |
Versameb AG |
Switzerland |
| Ameres, Stefan (IMBA 2012– Group Lead + Quantro Therapeutics 202007 Co-Founder + Scientific Adivsor) |
Researcher (university / research institute) |
Austrian Academy of Sciences (Österreichische Akademie der Wissenschaften, ÖAW) |
Austria |
| Amersdorfer, Peter (Lacerta Technologies GmbH 201401– CBO before Oridis Biomed 200705 Head BusDev) |
Chief Business Officer (CBO) |
OrthoSera (Group) |
Austria |
| Ameskamp, Nicole (Stada 201704 Managing Director of Norbitec GmbH) |
Managing Director |
Stada (Group) |
Germany |
| Ameye, Veronique (LumiraDx 202312 CEO) |
Chief Executive Officer (CEO) |
LumiraDx (Group) |
United Kingdom (GB) |
| Amiguet, Claude (Neode 2003– Director) |
President/Director/Head Business Group/Unit/Division |
Neode Science and Technology Park Neuchâtel |
Switzerland |
| Amitay, Oved (Centogene 201811– CBO before Arrett Neuroscience + Alnylam + Genzyme) |
Chief Business Officer (CBO) |
Centogene (Group) |
Germany |
| Ammendola, Aldo (4SC 2010– Director Strategic Planning + Regulatory Affairs before Director Developm + QuaNova) |
Business Development Manager / Strategy Manager |
4SC (Group) |
Germany |
| Ammer, Richard (Medice Pharma 201704 Executive Board Member) |
Board member, executive |
Medice (Group) |
Germany |
| Ammermann, Detmar (Eppendorf 2006–2019 CFO joined in 1992 LEFT 2019) |
Chief Financial Officer (CFO) |
Eppendorf (Group) |
Germany |
| Ammon (formerly Alexandru), Anca (Ammon Communications 202103 before MorphoSys + Affimed + MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
| Amon, Peter (OncoLead 201012 Managing Director) |
Managing Director |
OncoLead (Group) |
Germany |
| Amstutz, Patrick (Molecular Partners 201705– CEO before acting CEO before COO + Co-Founder) |
Chief Executive Officer (CEO) |
Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) |
Switzerland |
| An, Hyun Joo (Chungnam National Univ 201112 Professor at GRAST) |
Professor |
Chungnam National University |
Korea, Republic of |
| Anacleto, Joe (Bruker 201312 VP of Market Development before AB SCIEX + Life Technologies) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
United States (USA) |
| Anand, Mala (SAP 201610– President Intelligent Enterprise Solutions + Industries before Cisco 2007– 2016) |
President/Director/Head Business Group/Unit/Division |
SAP (Group) |
Germany |
| Ancher-Jensen, Henrik (Agilent 201309– SVP + President of Agilent Order Fulfillment before Dako + Chr Hansen) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
| Anderson, Bonnie H. (PinkDx 202404 CEO + Co-Founder before Veracyte 201409 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
PinkDx Inc. |
United States (USA) |
| Anderson, Daniel G. (MIT 201705 + CRISPR Therapeutics Scientific Founder + Advisory Board Member) |
Researcher (university / research institute) |
MIT (Massachusetts Institute of Technology) |
United States (USA) |
| Anderson, David (Ampersand 201905 General Partner) |
General Partner (venture partner) |
Ampersand (Group) |
United States (USA) |
| Anderson, Errik (Biomatics Capital 201811– Venture Partner + Alloy Therapeutics before Adimab + Compass Therapeutics) |
Venture Partner |
Biomatics Capital Partners (US) |
United States (USA) |
| Anderson, Mary L. (Xoma 200803– VP Business Developm before Merck-Serono) |
Business Development Manager / Strategy Manager |
Xoma (Group) |
United States (USA) |
| Anderson, N. Leigh (Plasma Proteome Institute 200808 + SCISCAPA Assay Technologies) |
mass spectrometry (MS) |
Plasma Proteome Institute (PPI) |
United States (USA) |
| Anderson, Timothy (Tim) (Cowen 201811 Cowen Healthcare Investments) |
Investment Manager |
Blue Owl Capital (Group) |
United States (USA) |
| Anderson, William N. (Bill) (Bayer 202306– CEO before Roche + Genentech + Biogen Idec + Raychem) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Ando, Goran (Nouscom 202311 Independent Chair) |
Board member, non-executive |
Nouscom (Group) |
Switzerland |
| André, Ludovic (Emerillon Capital 201607 Managing Director) |
Managing Director |
Emerillon Capital |
Canada |
| Andreou, Ioanna (Qiagen 200705 Senior Scientist RnD) |
n. a. |
Qiagen (Group) |
Germany |
| Andreu, Fernando (2curex 202101– before Indivumed + Sysmex Inostics) |
Chief Executive Officer (CEO) |
2cureX (Group) |
Denmark |
| Andrews, Richard (Rick) (Azitra –202010–202105 CEO RETIRED 5/21) |
Chief Executive Officer (CEO) |
Azitra Inc. |
United States (USA) |
| Andrews, Ron A. (Ronnie) (Life Technologies 201202– President Medical Sciences before GE Healthcare + CEO of Clarient) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Andreßen, Cordelia (Schleswig-Holstein 201107 Staatssekretärin) |
Administrative Officer (personnel) |
Schleswig-Holstein (govt region) |
Germany |
| Andrier, Gilles (Givaudan 201402 CEO) |
Chief Executive Officer (CEO) |
Givaudan (Group) |
Switzerland |
| Andriukaitis, Vytenis (EU (govt) 201801 Commissioner for Health and Food Safety) |
Minister |
EU (govt) |
Belgium |
| Ang, Robert (Vor Biopharma 201908– CEO before Neon Tx + Bavarian Nordic + Cadence Pharma + Frazier Healthcare Ventures) |
Chief Executive Officer (CEO) |
Vor Biopharma Inc. (Nasdaq: VOR) |
United States (USA) |
| Angehrn Pavik, Barbara (Asceneuron 202310– CEO before Vifor + Stepstone Pharma + Exelixis + Onyx + Amgen) |
Chief Executive Officer (CEO) |
Asceneuron S.A. |
Switzerland |
| Angenendt, Annette (MLM Medical Labs 201704– Marketing Manager before BIO.NRW + Univ Braunschweig) |
Sales Manager / Marketing Manager |
MLM Medical Labs (Group) |
Germany |
| Angermayer, Christian (Apeiron Investment 202010 Founder formerly Co-founder of Ribopharma) |
Company Founder |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta |
| Angloher, Daniel (Caire Health AI 202407 Managing Director + Co-Founder) |
Managing Director |
Caire Health AI GmbH (caire.ai) |
Germany |
| Angres, Brigitte (Cellendes GmbH 200907– Managing Director + Founder) |
Managing Director |
Cellendes GmbH |
Germany |
| Ankerhold, Richard (Carl Zeiss 200905 Business Unit Manager) |
n. a. |
Carl Zeiss (Group) |
Germany |
| Anninga, Bauke (Merck (DE) 202210 Principal at M Ventures) |
Principal (venture capital) |
Merck (DE) (Group) |
Netherlands |
| Antener, Mathias (Creoptix 202201 Head of Marketing) |
Public Relations Manager / Investor Relations Manager |
Spectris (Group) |
Switzerland |
| Antholz, Isabel (Mannin 202210 Managing Director Mannin GmbH) |
Managing Director |
Mannin (Group) |
Germany |
| Anthony, Daniel (Univ Oxford 201703 Prof at Dept of Pharmacology + Head of Experimental Neuropathology Lab) |
Professor |
University of Oxford |
United Kingdom (GB) |
| Antipov, Alexei |
n. a. |
PlasmaChem GmbH |
Germany |
| Antonelli, Pierluigi (Fresenius 202303– CEO of Fresenius Kabi formerly CEO of Angelini Pharma) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
Germany |
| Antonijevic, Irina (Sanofi 201208 Director Clinical Research at Sanofi US) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
France |
| Antonopoulos, Konstantinos (mk2 Biotechnologies 201902 CEO + Founder) |
Chief Executive Officer (CEO) |
mk2 Biotechnologies GmbH |
Germany |
| Antranikian, Garabed (TU Hamburg-Harburg 201109 Prof + President + ICBio-Initiative 200303 Coordinator) |
Professor |
Technical University Hamburg-Harburg (TUHH) |
Germany |
| Antwerpes, Frank |
n. a. |
DocCheck (Group) |
Germany |
| Antz, Cristoph (Veraxa Biotech 202106 Managing Director before Acousia Therapeutics + Elara + EMBL Ventures + Abeta) |
Managing Director |
Veraxa Biotech (Group) |
Germany |
| Anzalone, Christopher (Arrowhead Research 201503 CEO) |
Chief Executive Officer (CEO) |
Arrowhead (Group) |
United States (USA) |
| Anzenberger, Uwe (Link Medical 202104 General Manager at Link Medical Germany) |
General Manager (management) |
Link Medical (Group) |
Norway |
| Aoki, Yoshikazu (Asahi Kasei 202203 President of Asahi Kasei Pharma) |
President/Director/Head Business Group/Unit/Division |
Asahi Kasei (Group) |
Japan |
| Apicerno, Ken (Thermo Fisher 201003 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
United States (USA) |
| Apitius, Katharina (Heraeus 201403 Head Sales CEE at Heraeus Medical) |
Sales Manager / Marketing Manager |
Heraeus (Group) |
Germany |
| Apostel, Frank (R-Biopharm 201311 Director Business Development) |
Business Development Manager / Strategy Manager |
R-Biopharm (Group) |
Germany |
| Apostolopoulos, Petros (Bico 202108– CEO of Dispendix before 15 years at Festo) |
Chief Executive Officer (CEO) |
Bico (Group) |
Germany |
| Appel, Kurt (VivaCell 201104 Managing Director) |
Managing Director |
VivaCell Biotechnology GmbH |
Germany |
| Appel, Robert (MCH Group 201207 ILMAC Exhibition Manager) |
n. a. |
MCH Group AG |
Switzerland |
| Appelmann, Karl (Gentium 201111– Country Manager DE+ AT + CH before ViroLogik 201105 Managing Director) |
Regional manager |
Jazz Pharmaceuticals (Group) |
Switzerland |
| Appl, Thomas (Cellerata GmbH 201912– Managing Director + Founder before Apceth Biopharma + Rentschler / Cellca) |
Business Manager |
Cellerata GmbH |
Germany |
| Applebaum, Scott (VectivBio 202109– Chief Legal Officer + Corp Secretary before Trevena + Context Tx + Vitae + Medgenics |
General Counsel / Chief Legal Officer (CLO) |
Ironwood (Group) |
Switzerland |
| Apte, Arun (Premier Biosoft 201210 CEO) |
Chief Executive Officer (CEO) |
Premier Biosoft (Group) |
United States (USA) |
| Apter, Jason (Sigma-Aldrich 201504 VP + Managing Director Asia Pacific) |
Managing Director |
Merck (DE) (Group) |
Singapore |
| Arabian, Bruno (Ulysse Communication 201807 before Milestones 201511) |
Public Relations Manager / Investor Relations Manager |
Ulysse Communication GIE |
France |
| Aradhye, Shreeram (Novartis 201801 Global Head of Medical Affairs + CMO) |
Chief Medical Officer (CMO) |
Novartis (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
